Mr. Shawn Moniz reports

CANNVAS TO BEGIN TRADING ON THE CANADIAN SECURITIES EXCHANGE BRINGING ADVANCED TECHNOLOGY TO CANNABIS HEALTH SCIENCES

Cannvas Medtech Inc. has received conditional approval from the Canadian Securities Exchange for its application to list its common shares on the exchange. The company expects that its common shares will commence trading on the CSE under the ticker symbol MTEC on Tuesday, July 3, 2018, at 9:30 a.m. ET.

Based in Toronto, Ont., Cannvas Medtech operates in the cannabis health sciences space. The company is currently designing, as well as building, customer solutions that are intended to enable those utilizing the company's educational platform to harness the power of data and be better able to understand the entirety of the industry.

"The listing for Cannvas on the CSE represents the culmination of considerable hard work and effort by an exceptional and dedicated team who believe in the significant potential of our company and our technology," said Shawn Moniz, chief executive officer of Cannvas Medtech. "Medical cannabis has emerged to become an important economic and health care issue, with a significant potential to improve the health and wellness of patients worldwide. Our first offering is a scalable, patient-centric life sciences learning platform for the cannabis space. From patients and consumers to medical practitioners and licensed producers, our platform will allow for global interaction and define the future face of cannabis education. By listing on the CSE, we hope to gain access to capital to grow our business and continue our journey toward becoming a leading business technology company within the cannabis space."

Cannvas Medtech evolved from a need and ability to use technology and data to disrupt the status quo. With the world as a canvas, the company seeks to harness the power of data and design to build customer-centric initiatives in the medical technology sector that provide better outcomes for all shareholders. Cannvas Medtech is made up of four connected divisions offering design and execution expertise across advanced technology, data, blockchain and creative disciplines.

The CSE was recognized as a stock exchange in 2004, and operates to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets.

About Cannvas Medtech Inc.

Cannvas Medtech is a leading business technology company within the cannabis health sciences space. Cannvas Medtech designs and builds customer-centric solutions that enable its partners to harness the power of data to truly understand their customers, industry, and key business drivers.

We seek Safe Harbor.